SCHEMBL28373418

SCHEMBL28373418

O=C(NC1CC1)c1cc2cc(Nc3nccc(-c4cccnc4)n3)ccc2[nH]1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A1 P22736 2/20 0.68
SYK P43405 11/20 0.63
ABL1 P00519 6/20 0.52
BCR P11274 6/20 0.52
SRC P12931 5/20 0.52
PDGFRB P09619 3/20 0.52
PDGFRA P16234 3/20 0.52
PRKCA P17252 4/20 0.51
PRKCD Q05655 3/20 0.51
EGFR P00533 1/20 0.51
PRKACA P17612 1/20 0.51
PRKACG P22612 1/20 0.51
PRKACB P22694 1/20 0.51
ROCK2 O75116 1/20 0.51
ROCK1 Q13464 1/20 0.51
PRKD3 O94806 1/20 0.50
PRKCG P05129 1/20 0.50
PRKCB P05771 1/20 0.50
PRKCH P24723 1/20 0.50
PRKCI P41743 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28376607 0.93 SYK (0.67) NR4A1SYK
SCHEMBL28371930 0.85 NR4A1 (0.67) NR4A1SYKABL1BCRSRC
SCHEMBL28376014 0.85 ABL1 (0.67) NR4A1SYKABL1BCRSRC
SCHEMBL28546947 0.84 NR4A1 (0.66) NR4A1SYKABL1BCRSRC
SCHEMBL28377492 0.84 NR4A1 (0.66) NR4A1SYKABL1BCRSRC
SCHEMBL28377494 0.83 NR4A1 (0.83) NR4A1SYKABL1BCRSRC
SCHEMBL28541022 0.82 NR4A1 (0.73) NR4A1SYKABL1BCRSRC
SCHEMBL28375921 0.82 NR4A1 (0.63) NR4A1SYKABL1BCRSRC
SCHEMBL28376597 0.82 NR4A1 (0.71) NR4A1SYKABL1BCRSRC
SCHEMBL28372279 0.81 HDAC1 (0.72) NR4A1SYKABL1BCRSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107739368-B N-substituted-5- ((4-substituted pyrimidine-2-yl) amino) indole derivatives, and preparation method and application thereof 厦门大学 2020-02-14 CN disclosed